As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...

DUBLIN--(BUSINESS WIRE)--The "Enterprise Tech Ecosystem Series: GSK plc 2024" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights into company's tech ...

Me is potentially selling more than just your genetic data—the personal survey info it collected is just as much a privacy ...

Vaxcyte, Inc.'s stock fell 50% despite positive vaccine results. See how FDA uncertainty, competition, and Phase 3 delays ...

London: GSK plc has announced that the Company has received US Food and Drug Administration (FDA) approval for Blujepa ...

Blujepa marks the first new oral antibiotic to gain FDA approval for uncomplicated urinary tract infections in nearly 30 ...

Neil Woodford, one of the UK’s most high profile fund managers, has sold his long-standing stake in GlaxoSmithKline, saying he believes the company will continue to underperform. Woodford ...

On the upside, advertising giant WPP was the standout gainer on the index, having slumped on Tuesday after Bank of America Merrill Lynch said it expects first-quarter results on 25 April to show a ...

New York Attorney General Letitia James on Tuesday urged 23andMe customers to secure their data in light of rising privacy ...

If you were a 23andMe customer, your genetic and personal information could be used in civil or criminal cases, targeted ...

Discover why BVNKF's vaccine innovations, growth catalysts, and compelling valuation after a 52% pullback make it a strong ...